These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15731739)
1. Nucleoside/nucleotide reverse transcriptase inhibitor drug interactions. Samarasinghe YP; Boffito M; Di Perri G J HIV Ther; 2004 Nov; 9(4):79-86. PubMed ID: 15731739 [TBL] [Abstract][Full Text] [Related]
2. [Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors]. Bonora S; Calcagno A; Gonzalez de Requena D; Bargiacchi O; Di Perri G Infez Med; 2006 Jun; 14(2):61-70. PubMed ID: 16891850 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors. Weiss J; Weis N; Ketabi-Kiyanvash N; Storch CH; Haefeli WE Eur J Pharmacol; 2008 Jan; 579(1-3):104-9. PubMed ID: 18037401 [TBL] [Abstract][Full Text] [Related]
4. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience. Joly V; Yeni P Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761 [TBL] [Abstract][Full Text] [Related]
5. Interactions between non-nucleoside reverse transcriptase inhibitor and nucleoside reverse transcriptase inhibitor mutations: phenotypes and mechanisms. Shulman NS Curr Opin HIV AIDS; 2007 Mar; 2(2):88-93. PubMed ID: 19372872 [TBL] [Abstract][Full Text] [Related]
6. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients? Cuzin L; Allavena C; Morlat P; Dellamonica P AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogue reverse transcriptase inhibitor options: a re-examination of the class. Hammer SM Top HIV Med; 2006; 14(4):140-3. PubMed ID: 17114828 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Menéndez-Arias L Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247 [TBL] [Abstract][Full Text] [Related]
9. Drug transporters relevant to HIV therapy. Thomas SA J HIV Ther; 2004 Nov; 9(4):92-6. PubMed ID: 15731741 [TBL] [Abstract][Full Text] [Related]
11. Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools. Vela JE; Miller MD; Rhodes GR; Ray AS Antivir Ther; 2008; 13(6):789-97. PubMed ID: 18839780 [TBL] [Abstract][Full Text] [Related]
12. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760 [TBL] [Abstract][Full Text] [Related]
13. Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors. Geretti AM AIDS Rev; 2006; 8(4):210-20. PubMed ID: 17219736 [TBL] [Abstract][Full Text] [Related]
14. Are all non-thymidine analogue backbones appropriate for treating antiretroviral-naïve patients? Waters LJ; Nelson MR Int J Clin Pract; 2005 Dec; 59(12):1452-8. PubMed ID: 16351678 [TBL] [Abstract][Full Text] [Related]
16. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors. Ghosn J; Chaix ML; Delaugerre C AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038 [TBL] [Abstract][Full Text] [Related]